two pivotal phase 3 clinical trials

  1. Anonymous

    Novavax, Switzerland: Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

    PRESS RELEASE PR Newswire Apr. 13, 2022, 06:00 AM Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Switzerland GAITHERSBURG, Md., April 13, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and...
    • Anonymous
    • Thread
    • chief executive officer novavax clinical studies frequency category country: unknown important safety information adverse event reporting instructions myalgia arthralgia injection site tenderness pain fatigue novavax conditional marketing authorization cma novavax global authorization website nuvaxovid covid 19 vaccine recombinant adjuvanted stanley c erck president two pivotal phase 3 clinical trials
    • Replies: 12
    • Forum: 2022
Back
Top Bottom